CZ298371B6 - Dávkovací forma ibuprofenu a zpusob její prípravy - Google Patents

Dávkovací forma ibuprofenu a zpusob její prípravy Download PDF

Info

Publication number
CZ298371B6
CZ298371B6 CZ0261798A CZ261798A CZ298371B6 CZ 298371 B6 CZ298371 B6 CZ 298371B6 CZ 0261798 A CZ0261798 A CZ 0261798A CZ 261798 A CZ261798 A CZ 261798A CZ 298371 B6 CZ298371 B6 CZ 298371B6
Authority
CZ
Czechia
Prior art keywords
dosage form
ibuprofen
weight
sodium
bicarbonate
Prior art date
Application number
CZ0261798A
Other languages
Czech (cs)
English (en)
Other versions
CZ261798A3 (cs
Inventor
Ashley Price@Ian
Original Assignee
Reckitt Benckiser Healthcare (Uk) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare (Uk) Limited filed Critical Reckitt Benckiser Healthcare (Uk) Limited
Publication of CZ261798A3 publication Critical patent/CZ261798A3/cs
Publication of CZ298371B6 publication Critical patent/CZ298371B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ0261798A 1996-02-21 1997-02-19 Dávkovací forma ibuprofenu a zpusob její prípravy CZ298371B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition

Publications (2)

Publication Number Publication Date
CZ261798A3 CZ261798A3 (cs) 1998-11-11
CZ298371B6 true CZ298371B6 (cs) 2007-09-12

Family

ID=10789176

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ0261798A CZ298371B6 (cs) 1996-02-21 1997-02-19 Dávkovací forma ibuprofenu a zpusob její prípravy

Country Status (25)

Country Link
US (1) US20020034540A1 (enExample)
EP (1) EP0881899B1 (enExample)
JP (2) JP2000507922A (enExample)
KR (1) KR19990087084A (enExample)
CN (1) CN1215989A (enExample)
AT (1) ATE273696T1 (enExample)
AU (1) AU722991B2 (enExample)
BG (1) BG64165B1 (enExample)
CA (1) CA2246344C (enExample)
CZ (1) CZ298371B6 (enExample)
DE (1) DE69730314T2 (enExample)
DK (1) DK0881899T3 (enExample)
ES (1) ES2227670T3 (enExample)
GB (1) GB9603699D0 (enExample)
HU (1) HUP9901454A3 (enExample)
IL (1) IL125803A0 (enExample)
NO (1) NO983825L (enExample)
NZ (1) NZ331416A (enExample)
PL (1) PL187383B1 (enExample)
PT (1) PT881899E (enExample)
RU (1) RU2182000C2 (enExample)
SK (1) SK285032B6 (enExample)
UA (1) UA55407C2 (enExample)
WO (1) WO1997030699A2 (enExample)
ZA (1) ZA971446B (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
AU2002255190A1 (en) * 2001-04-10 2002-10-28 Fakhreddin Jamali Composition for enhanced absorption of nsaids
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
EP1585500B8 (en) * 2002-12-20 2017-07-26 Auritec Pharmaceuticals Coated particles for sustained-release pharmaceutical administration
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
EP3216445A1 (en) * 2004-05-28 2017-09-13 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
PL1916994T3 (pl) * 2004-06-29 2014-05-30 Takeda Pharma As Wytwarzanie kompozycji farmaceutycznej o szybkim uwalnianiu leków nierozpuszczalnych w wodzie i kompozycje farmaceutyczne otrzymywane sposobem według wynalazku
JP2008509207A (ja) * 2004-08-12 2008-03-27 レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド 溶融押出しにより作製するパラセタモール、ｎｓａｉｄ及び糖アルコールを含む顆粒
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
WO2006056042A1 (en) * 2004-11-03 2006-06-01 Equitech Corporation Nsaid compositions exhibiting clinical superiority
ES2523988T3 (es) * 2005-02-09 2014-12-03 Boehringer Ingelheim International Gmbh Comprimidos recubiertos que contienen lisinato de ibuprofeno
PT2559430E (pt) 2005-03-22 2015-10-09 Stada Arzneimittel Ag Ibuprofeno solubilizado
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
US20080269334A1 (en) * 2005-09-19 2008-10-30 Albemarle Corporation Highly Concentrated Pourable Aqueous Solutions Of Potassium Ibuprofen, Their Preparation And Their Use
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20070521A7 (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US7749537B2 (en) 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
WO2009135946A1 (en) * 2008-05-09 2009-11-12 Atacama Labs Oy Method and apparatus for dry granulation
US9629809B2 (en) * 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629806B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
EP2323976A4 (en) * 2008-08-14 2014-07-02 Shasun Chemicals And Drugs Ltd ARYLALKYLCARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION THEREOF AND GALENIC FORMS
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
TWI504393B (zh) * 2009-06-22 2015-10-21 惠氏有限責任公司 製備包含異丁苯丙酸鈉之醫藥組合物之方法
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
WO2015016256A1 (ja) * 2013-07-30 2015-02-05 ライオン株式会社 錠剤
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) * 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
EP3753921A1 (en) 2014-07-02 2020-12-23 ObsEva S.A. Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one o-methyloxime useful in methods of treating conditions related to the ot-r activity
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002266A1 (en) * 1987-09-17 1989-03-23 Mallinckrodt, Inc. A free-flowing granular composition containing ibuprofen and a method for its preparation
EP0478838A1 (de) * 1989-07-07 1992-04-08 Pharmatrans Sanaq Ag Ibuprofen- und S-(+)-Ibuprofen Zubereitungen und Verfahren zu ihrer Herstellung
WO1993023026A1 (de) * 1992-05-21 1993-11-25 Pharmatrans Sanaq Ag 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung
EP0607467A1 (de) * 1992-12-01 1994-07-27 Spirig Ag Pharmazeutische Präparate S(+)-Ibuprofen enthaltende Arzneimittel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
AU8320387A (en) * 1986-10-22 1988-05-25 Upjohn Company, The Treatment of gingivitis with ibuprofen or flurbiprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
UA34430C2 (uk) * 1991-05-13 2001-03-15 Дзе Бутс Компані Плс S(-)-2-(4-ізобутилфеніл)пропіонат натрію дигідрат, придатний для лікування запалення, болю і гіпертермії, фармацевтична композиція на його основі та спосіб одержання s(-)-2-(4-ізобутилфеніл)пропіонату натрію

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002266A1 (en) * 1987-09-17 1989-03-23 Mallinckrodt, Inc. A free-flowing granular composition containing ibuprofen and a method for its preparation
EP0478838A1 (de) * 1989-07-07 1992-04-08 Pharmatrans Sanaq Ag Ibuprofen- und S-(+)-Ibuprofen Zubereitungen und Verfahren zu ihrer Herstellung
WO1993023026A1 (de) * 1992-05-21 1993-11-25 Pharmatrans Sanaq Ag 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung
EP0607467A1 (de) * 1992-12-01 1994-07-27 Spirig Ag Pharmazeutische Präparate S(+)-Ibuprofen enthaltende Arzneimittel

Also Published As

Publication number Publication date
CN1215989A (zh) 1999-05-05
SK285032B6 (sk) 2006-05-04
AU722991B2 (en) 2000-08-17
WO1997030699A2 (en) 1997-08-28
PL187383B1 (pl) 2004-06-30
BG64165B1 (bg) 2004-03-31
BG102744A (bg) 1999-05-31
HUP9901454A3 (en) 2001-04-28
EP0881899B1 (en) 2004-08-18
NO983825L (no) 1998-10-20
CA2246344C (en) 2009-01-20
HUP9901454A2 (hu) 1999-08-30
ES2227670T3 (es) 2005-04-01
PT881899E (pt) 2004-12-31
JP2009073847A (ja) 2009-04-09
UA55407C2 (uk) 2003-04-15
DK0881899T3 (da) 2004-12-20
CZ261798A3 (cs) 1998-11-11
RU2182000C2 (ru) 2002-05-10
CA2246344A1 (en) 1997-08-28
NO983825D0 (no) 1998-08-20
IL125803A0 (en) 1999-04-11
ATE273696T1 (de) 2004-09-15
US20020034540A1 (en) 2002-03-21
JP2000507922A (ja) 2000-06-27
SK114298A3 (en) 1999-01-11
PL328465A1 (en) 1999-02-01
WO1997030699A3 (en) 1997-10-09
AU1793797A (en) 1997-09-10
NZ331416A (en) 2000-02-28
EP0881899A2 (en) 1998-12-09
KR19990087084A (ko) 1999-12-15
GB9603699D0 (en) 1996-04-17
ZA971446B (en) 1997-11-25
DE69730314T2 (de) 2005-08-18
DE69730314D1 (de) 2004-09-23

Similar Documents

Publication Publication Date Title
CZ298371B6 (cs) Dávkovací forma ibuprofenu a zpusob její prípravy
JP2009073847A6 (ja) イブプロフェンの剤型
JP5537927B2 (ja) 口腔内崩壊錠
JP4638964B2 (ja) プロトンポンプ阻害剤およびｎｓａｉｄからなる経口用医薬剤形
JP3589977B2 (ja) 活性成分としてクロドロン酸塩および賦形剤としてケイ化微晶質セルロースを含む医薬製剤
EP1058538B2 (en) Fast disintegrating tablets
RU2300368C2 (ru) Содержащая ибупрофен композиция
KR20010086062A (ko) 고가용성 약물용 서방성 메트리스 시스템
JPH1017497A (ja) 徐放性製剤およびその製造方法
CA2761212A1 (en) Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of it manufacturing
EP1100472B1 (en) Pharmaceutical compositions comprising ibuprofen and domperidone
US20090202633A1 (en) Extended release formulations of guaifenesin
CA2589079A1 (en) Nsaid compositions exhibiting clinical superiority
EP0975337B1 (en) Fast release compressed tablet of flurbiprofen
JP2012046454A (ja) 内服用錠剤およびその製造方法
JP2006335771A (ja) 徐放性製剤およびその製造方法
CN114144168A (zh) 达鲁酰胺的药物组合物
JP2016503782A (ja) Ｎ−［５−［２−（３，５−ジメトキシフェニル）エチル］−２ｈ−ピラゾール−３−イル］−４−［（３ｒ，５ｓ）−３，５−ジメチルピペラジン−１−イル］ベンズアミドの医薬製剤
MXPA98006688A (en) Dosage form of ibuprophene
JP2005015371A (ja) プソイドエフェドリン類含有徐放性固形製剤
HK40068856A (en) Pharmaceutical composition of darolutamide
RU2007147951A (ru) Фармацевтические рецептуры немикронизированного (4-хлорфенил){4-(4-пиридилметил)-фталазин-1-ила} и его солей с немедленным высвобождением и высоким содержанием лекарственного средства

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20140219